Neuland Laboratories Limited (BOM:524558)

Neuland Laboratories Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 9, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	201,608	154,946	80,588	23,087	13,171	26,788
Market Cap Growth	27.97%	92.27%	249.07%	75.28%	-50.83%	636.62%
Enterprise Value	200,783	154,137	80,232	24,941	15,076	28,580
Last Close Price	15713.90	12066.95	6265.25	1788.67	1016.15	2063.59
PE Ratio	114.47	59.57	26.86	14.12	20.64	33.22
Forward PE	53.69	44.12	25.58	20.20	15.19	28.71
PS Ratio	15.16	10.49	5.17	1.94	1.38	2.86
PB Ratio	13.22	10.16	6.28	2.32	1.57	3.41
P/TBV Ratio	16.25	12.49	8.05	3.24	2.36	5.32
P/FCF Ratio	-	139.69	68.58	13.49	-	31.90
P/OCF Ratio	-	48.82	30.86	9.73	21.81	14.15
PEG Ratio	1.19	0.59	0.59	0.59	0.59	0.59
EV/Sales Ratio	15.10	10.44	5.15	2.09	1.58	3.05
EV/EBITDA Ratio	84.56	47.53	17.49	8.93	10.74	19.72
EV/EBIT Ratio	116.57	58.16	19.89	10.82	15.69	26.07
EV/FCF Ratio	-	138.96	68.28	14.58	-	34.04
Debt / Equity Ratio	0.10	0.10	0.07	0.13	0.29	0.23
Debt / EBITDA Ratio	0.66	0.48	0.21	0.46	1.67	1.23
Debt / FCF Ratio	-	1.42	0.81	0.75	-	2.17
Asset Turnover	-	0.74	0.91	0.80	0.70	0.73
Inventory Turnover	-	2.04	2.33	2.26	2.16	2.38
Quick Ratio	-	1.21	1.10	0.95	0.69	0.63
Current Ratio	-	2.45	2.15	1.73	1.60	1.49
Return on Equity (ROE)	-	18.53%	26.36%	17.83%	7.85%	10.78%
Return on Assets (ROA)	-	8.26%	14.77%	9.73%	4.44%	5.36%
Return on Capital (ROIC)	7.04%	10.83%	20.16%	13.08%	5.86%	7.05%
Return on Capital Employed (ROCE)	-	15.50%	28.70%	20.20%	9.40%	11.50%
Earnings Yield	0.87%	1.68%	3.72%	7.08%	4.85%	3.01%
FCF Yield	-	0.72%	1.46%	7.41%	-2.83%	3.13%
Dividend Yield	0.08%	0.10%	0.22%	0.56%	0.49%	0.24%
Payout Ratio	-	6.91%	4.28%	3.92%	6.03%	3.18%
Buyback Yield / Dilution	-0.01%	-	-	-	-	-
Total Shareholder Return	0.07%	0.10%	0.22%	0.56%	0.49%	0.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.